ANAHEIM, Calif. – February 6, 2018 – Dow Medical Solutions, a business unit of the DowDuPont Specialty Products Division, launched today to the U.S. healthcare market two new Dow Corning® QP1-33X0 Liquid Silicone Rubber (LSR) grades and new Dow Corning® QP1-5040 Self-Adhesive LSR grade. Each is a low-temperature cure (LTC) technology. These new additions to the company’s portfolio of LSR solutions support a broader range of rigid plastic substrates in overmolding applications and can enhance patients’ experiences, while delivering manufacturing and cost advantages. Dow Medical Solutions unveiled the new materials here at MD&M West 2018, in booth #2021, Hall D. “Population aging is driving the need for greater affordability, usability and comfort in medical devices, and our innovative LSRs can make an important contribution to a wide range of applications,” said Marie Crane, medical materials market leader for Dow Medical So... View more and related images
Dow Corning
Healthcare
Dow Medical Solutions, a business unit of the DowDuPont Specialty Products Division, will debut at MD&M West 2018 (Hall D, Booth #2021), two new liquid silicone rubber (LSR) technologies to support a broader range of rigid plastic substrates for overmolding applications. These new elastomeric products give designers and manufacturers greater options for creating differentiated devices with improved safety and durability. View more and related images
Dow Corning, a global leader in silicones, silicon-based technology and innovation and a wholly owned subsidiary of The Dow Chemical Company, announced here today at MD&M West 2017 (booth 1921), that it is investing in state-of-the-art capabilities and new product technologies. In particular, the company is expanding its North American Healthcare Application Center in Midland, Mich. with additional capabilities for characterizing material performance to support advanced application development and help customers develop new innovations. View more and related images
Dow Corning, a global leader in silicones, silicon-based technology and innovation and a wholly owned subsidiary of The Dow Chemical Company, sees the role of specialized adhesive technologies as a key driver of this growth – especially in skin-adhered medical devices, a major segment of the wearables market. Selecting the right adhesive for each device type – based upon factors such as duration of wear, skin condition, and device size and weight – can have a significant impact on patient compliance and, ultimately, treatment efficacy. Advancements in silicone-based adhesive technologies are intended to offer expanded flexibility to support new device designs while meeting patient needs for comfort and ease of use. View more and related images
Dow Corning, a global leader in silicones, silicon-based technology and innovation and a wholly owned subsidiary of The Dow Chemical Company, will announce at MD&M West 2017 the expansion of its Midland-based North American Healthcare Application Center, together with the latest additions to its growing healthcare product portfolio. View more and related images
Dow Corning, a global leader in silicones, silicon-based technology and innovation, is introducing its strongest soft skin adhesive (SSA) to date here at COMPAMED 2016 View more and related images
Nov. 14, 2016– Dow Corning, a global leader in silicones, silicon-based technology and innovation, is introducing its strongest soft skin adhesive (SSA) to date here at COMPAMED 2016, Hall 8a, Stand M27, Nov. 14-17. Dow Corning® MG 7-1010 Soft Skin Adhesive bridges the gap between the company’s high-adhesion pressure sensitive adhesives (PSAs) and gentle-adhesion SSAs, to deliver strong attachment for today’s wearable medical devices. View more and related images
Dow Corning, a global leader in silicones, silicon-based technology and innovation, is introducing two new, cutting-edge solutions at CPhI Worldwide 2016 in Barcelona, Spain, Oct. 4-6. The company is exhibiting a kit of sample formulations for acne management featuring Dow Corning Topical Ingredients, and three new silicone blends for skin barrier applications and adhesive and film removal. Also at Stand 4H64, which it shares with Biesterfeld Specialty Chemicals, a European distributor, Dow Corning is presenting other highlights from its extensive portfolio. These include the unique digital Topical Formulation Box and two topical ingredients from this online tool: a solid resin film-former and a semi-occlusive wax for texture modification. View more and related images
Dow Corning, a global leader in silicones, silicon-based technology and innovation, is introducing two new, cutting-edge solutions at CPhI Worldwide 2016 in Barcelona, Spain, Oct. 4-6. The company is exhibiting a kit of sample formulations for acne management featuring Dow Corning Topical Ingredients, and three new silicone blends for skin barrier applications and adhesive and film removal. View more and related images
Dow Corning, a global leader in silicones, silicon-based technology and innovation, will present an educational webinar titled, “Effective Silicone-based Topical Formulations – How to Improve Efficacy and Patient Compliance,” on June 7 at 10 a.m. EDT. Myriam Delvaux, global pharmaceutical marketing leader for Dow Corning Healthcare will lead the webinar and explain how silicone-based ingredients and excipients can help generate innovative product forms with pleasant aesthetics for improved drug delivery and patient compliance. View more and related images